首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   102618篇
  免费   6602篇
  国内免费   440篇
耳鼻咽喉   1165篇
儿科学   2568篇
妇产科学   1887篇
基础医学   12767篇
口腔科学   1800篇
临床医学   10838篇
内科学   20540篇
皮肤病学   1481篇
神经病学   10333篇
特种医学   4007篇
外国民族医学   3篇
外科学   16890篇
综合类   1105篇
一般理论   131篇
预防医学   8323篇
眼科学   2115篇
药学   6574篇
中国医学   104篇
肿瘤学   7029篇
  2023年   522篇
  2022年   399篇
  2021年   2145篇
  2020年   1368篇
  2019年   2167篇
  2018年   2663篇
  2017年   1925篇
  2016年   2072篇
  2015年   2359篇
  2014年   3535篇
  2013年   4847篇
  2012年   7790篇
  2011年   8196篇
  2010年   4687篇
  2009年   4221篇
  2008年   7279篇
  2007年   7632篇
  2006年   7365篇
  2005年   7057篇
  2004年   6873篇
  2003年   6163篇
  2002年   5827篇
  2001年   893篇
  2000年   642篇
  1999年   941篇
  1998年   1241篇
  1997年   937篇
  1996年   762篇
  1995年   682篇
  1994年   596篇
  1993年   573篇
  1992年   450篇
  1991年   424篇
  1990年   335篇
  1989年   302篇
  1988年   283篇
  1987年   295篇
  1986年   257篇
  1985年   288篇
  1984年   312篇
  1983年   259篇
  1982年   333篇
  1981年   283篇
  1980年   217篇
  1979年   97篇
  1978年   131篇
  1977年   106篇
  1976年   87篇
  1975年   73篇
  1973年   90篇
排序方式: 共有10000条查询结果,搜索用时 62 毫秒
1.
2.
3.
4.
5.
Vaccination is a vital health care initiative to prevent individual and population infection. To increase vaccination rates the federal government implemented the ‘No Jab, No Pay’ policy, where eligibility for several government benefits required children to be fully vaccinated by removing ‘conscientious objections’ and expanding the age range of children whose families receive benefits. This study assesses the impact of this policy at a local area within a single medical practice community in NSW, Australia. A retrospective clinical audit was performed between 2012 and 2017 on a single general practice's vaccination records for children ≤19 years. Catch-up vaccinations were assessed based on age at vaccination. Incidence of catch-up vaccinations was assessed for each of four years before and two years after the implementation of the ‘No Jab, No Pay’ policy in January 2016, along with the age of children and vaccination(s) given. Catch-up vaccinations were assessed temporally either side of implementation of ‘No Jab, No Pay’. Comparing the average annual vaccination catch-up incidence rate of 6.2% pre-implementation (2012–2015), there was an increase to 9.2% in 2016 (p < .001) and 7.8% in 2017 (p = .027). Secondary outcome measurement of catch-up vaccination incidence rates before (2012–2015) and after (2016–2017) ‘No Jab, No Pay’ implementation showed statistically significant increases for children aged 8–11 years (3.2%–5.6%, p = .038), 12–15 years (7.5%–14.7%, p < .001) and 16–19 years (3.3%–10.2%, p < .001) along with a statistically significant reduction in children aged 1–3 years (11.4%–6.2%, p = .015). Also, catch-up rates for DTPa significantly increased after program implementation. This study demonstrates that the Australian federal government vaccination policy ‘No Jab, No Pay’ was coincident with an increase in catch-up vaccinations within a rural NSW community served by one medical practice, especially for older children.  相似文献   
6.
7.
International Journal of Mental Health and Addiction - One of the relatively new negative consequences of smartphone use is “phubbing” (snubbing someone while an individual checks their...  相似文献   
8.
9.
10.

Objective

Comparative survival between neoadjuvant chemotherapy and adjuvant chemotherapy for patients with cT2-4N0-1M0 non–small cell lung cancer has not been extensively studied.

Methods

Patients with cT2-4N0-1M0 non–small cell lung cancer who received platinum-based chemotherapy were retrospectively identified. Exclusion criteria included stage IV disease, induction radiotherapy, and targeted therapy. The primary end point was disease-free survival. Secondary end points were overall survival, chemotherapy tolerance, and ability of Response Evaluation Criteria In Solid Tumors response to predict survival. Survival was estimated using the Kaplan–Meier method, compared using the log-rank test and Cox proportional hazards models, and stratified using matched pairs after propensity score matching.

Results

In total, 330 patients met the inclusion criteria (n = 92/group after propensity-score matching; median follow-up, 42 months). Five-year disease-free survival was 49% (95% confidence interval, 39-61) for neoadjuvant chemotherapy versus 48% (95% confidence interval, 38-61) for adjuvant chemotherapy (P = .70). On multivariable analysis, disease-free survival was not associated with neoadjuvant chemotherapy or adjuvant chemotherapy (hazard ratio, 1.1; 95% confidence interval, 0.64-1.90; P = .737), nor was overall survival (hazard ratio, 1.21; 95% confidence interval, 0.63-2.30; P = .572). The neoadjuvant chemotherapy group was more likely to receive full doses and cycles of chemotherapy (P = .014/0.005) and had fewer grade 3 or greater toxicities (P = .001). Response Evaluation Criteria In Solid Tumors response to neoadjuvant chemotherapy was associated with disease-free survival (P = .035); 15% of patients receiving neoadjuvant chemotherapy (14/92) had a major pathologic response.

Conclusions

Timing of chemotherapy, before or after surgery, is not associated with an improvement in overall or disease-free survival among patients with cT2-4N0-1M0 non–small cell lung cancer who undergo complete surgical resection.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号